Latest News

 Filter by Provider

Use patience and fundamentals to navigate volatile IPOs.

Who doesn't want some extra passive income?

A 13.6% plunge in SpaceX tests investor risk, volatility, and earnings expectations.

AI could drive SpaceX's growth. It's also driving up costs.

Palisade Bio (NASDAQ:PALI) said it is advancing its lead drug candidate, PALI-2108, into Phase II studies for ulcerative colitis and Crohn’s disease after completing its Phase I program. Chief Executive Officer JD Finley said PALI-2108 is a once-daily oral phosphodiesterase 4, or PDE4, inhibitor de

Every year, NFL teams spend months studying the next class of potential stars. My colleague Louis Navellier sees a similar dynamic unfolding in the stock market today. After years of mega-cap dominance, smaller companies are beginning to take the lead—but that doesn’t mean every small-cap stock deserves a place in your portfolio.

The exuberance surrounding Intel's stock is getting a bit too high.

This biotech has grabbed plenty of headlines recently.

Lululemon faces mounting governance risks as investors question leadership credibility.

One of the most challenging decisions to make as you near retirement is when to claim Social Security benefits. Here are five reasons 65 might be the sweet spot.

Should you buy at the high? The answer might surprise you.

SpaceX has some impressive business, but its stock has been anything but.

Strong leasing demand and limited new supply are boosting top-tier office REITs like SL Green, BXP and Hudson Pacific, which trade far cheaper than data-center REITs Equinix and Digital Realty.

Investors can become their own worst enemies if their expectations aren't grounded in reality.

Xenon Pharmaceuticals (NASDAQ:XENE) said it has filed its first new drug application for azetukalner as a treatment for focal-onset seizures, while pausing portions of its late-stage psychiatry program to evaluate changes intended to improve tolerability. Speaking at the 2026 TD Cowen Neuropsychiat

Broadcom and Marvell are both gaining from the AI infrastructure boom, but one stock offers a better risk-reward proposition.

Green Thumb is profitable, cash-generative, and still reasonably valued.

Palo Alto Networks and Fortinet shares are up 112% and 125% this year, respectively, as AI-driven demand for cybersecurity fuels strong earnings and technical breakouts for both stocks.

The demand for Intel's server CPUs is exceeding supply by a big margin.

This monthly dividend payer has raised its payout 136 times since 1994, and new data center and European deals could fuel further growth.

Dividend growth stocks have historically weathered market storms.

These high-yielding stocks offer very durable dividends.

Ford edges out GM in five of the last eight quarters, but the gap remains razor-thin—a pattern that could shift either way.

Meta is catching up with AI competitors, and investors are noticing.

Huron Consulting Group (NASDAQ:HURN) expects continued double-digit growth through 2029 as healthcare providers, higher-education institutions and commercial clients navigate financial pressure, technology modernization and regulatory complexity, Chief Financial Officer John Kelly said during the Si

They are expected to go up again in October.

Greg Abel began using Berkshire Hathaway's cash hoard, suggesting that the portfolio may be where he wants it.

Bloom Energy, Ciena, and Twilio show strong revenue growth, raised guidance, and analyst support as AI infrastructure buildout continues across power, networking, and orchestration.

The company recently delivered some exciting trial data, but it also needs to deliver in the second part of the trial.

The utility company lives up to the industry's reputation for producing good -- though not thrilling -- investment income.

Commerzbank (ETR:CBK) CEO Bettina Orlopp said the lender is entering a new phase as regulatory approvals related to UniCredit’s investment are expected by the end of the year or early next year, while emphasizing that the bank remains independently managed and focused on meeting its existing financi

Mining stocks are back in favour driven by higher average realized prices as gold, silver, and copper gained steam and hit record high.

Many stocks in the nuclear space have lost ground this year.

The average investor out there can learn so much from the Oracle of Omaha, even though his role has changed.

CAVA stock fell alongside restaurant peers after weak August traffic data, but Q2 results showed strong sales and unit growth despite slipping margins and a still-rich valuation.

Three top Canadian stocks just posted strong results, yet their shares have pulled back. Here's why $500 could work hard in each of them this September.

The company's deliveries report is eagerly awaited, as it offers a sneak peek at its third-quarter earnings.

The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.

Here are three top dividend stocks that could be excellent additions to your TFSA.

A projected well-above-average Social Security raise in 2027 should lead to some unique situations for beneficiaries.

Before jumping in, do the math.

Brookfield Infrastructure Partners is a top "set and forget" dividend stock for growing income. Here's why.

If the artificial intelligence revolution doesn't live up to the hype, the whole market is going to feel it.

Arianespace was Amazon's last chance to keep its Leo satellite constellation growing this year. No longer.

Prestige Consumer Healthcare (NYSE:PBH) said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives. Speaking at a fireside chat, Chief Fina

Canada’s “energy superpower” pitch isn’t just about resources; it’s about the pipes, fuel, and wires that turn them into exports.

SPY's tech-heavy structure and RSP's equal-weight, rate-sensitive value tilt carry different risks; comparing yields, valuations, and margins helps investors position portfolios for shifting Treasury rates.

Investors have an increasingly attractive income and growth opportunity in PepsiCo stock.

The company's shares may have peaked at $341 per share.

A little over half of Americans own stock, which means that too many people are missing out on the wealth-building power of capitalism.